JNJ - JOHNSON & JOHNSON
152.15
-0.340 -0.223%
Share volume: 8,458,715
Last Updated: Fri 31 Jan 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.28%
PREVIOUS CLOSE
CHG
CHG%
$152.49
-0.72
0.00%
View ratios
| Fiscal Date | 2023-07-02 | 2023-10-01 | 2023-12-31 | 2024-03-31 | 2024-03-31 | 2024-06-30 | 2024-06-30 | 2024-09-29 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-07-31 | 2023-10-27 | 2024-02-16 | 2024-05-01 | 2024-05-01 | 2024-07-25 | 2024-07-25 | 2024-10-23 | |
| Assets | |||||||||
| Total Assets | 191.686 B | 166.061 B | 167.558 B | 171.966 B | 171.966 B | 181.088 B | 181.088 B | 178.287 B | |
| Current Assets | 60.567 B | 53.703 B | 53.495 B | 57.002 B | 57.002 B | 57.817 B | 57.817 B | 53.249 B | |
| Inventories | 12.888 B | 11.198 B | 11.181 B | 11.383 B | 11.383 B | 12.169 B | 12.169 B | 12.603 B | |
| Other Current Assets | 2.397 B | 4.196 B | 4.514 B | 0.000 | 4.455 B | 0.000 | 4.379 B | 0.000 | |
| Short Term Investments | 2.397 B | 4.196 B | 4.514 B | 745.000 M | 4.455 B | 597.000 M | 4.379 B | 317.000 M | |
| Total Receivables | 16.777 B | 14.798 B | 14.873 B | 0.000 | 14.946 B | 0.000 | 15.794 B | 0.000 | |
| Current Cash | 28.505 B | 23.511 B | 22.927 B | 25.473 B | 26.218 B | 24.878 B | 25.475 B | 19.980 B | |
| Total Non-current Assets | 131.119 B | 112.358 B | 114.063 B | 0.000 | 114.964 B | 0.000 | 123.271 B | 0.000 | |
| Property Plant Equipment | 20.576 B | 18.821 B | 19.898 B | 19.632 B | 19.632 B | 19.748 B | 19.748 B | 20.479 B | |
| Other Assets | 10.078 B | 13.133 B | 9.680 B | 95.332 B | 14.125 B | 103.523 B | 10.544 B | 104.559 B | |
| Intangible Assets | 46.246 B | 35.021 B | 34.175 B | 0.000 | 34.286 B | 0.000 | 39.725 B | 0.000 | |
| Goodwill | 45.440 B | 36.124 B | 36.558 B | 0.000 | 36.616 B | 0.000 | 44.250 B | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 191.686 B | 166.061 B | 167.558 B | 171.966 B | 171.966 B | 181.088 B | 181.088 B | 178.287 B | |
| Total liabilities | 116.537 B | 94.833 B | 98.784 B | 101.946 B | 101.946 B | 109.550 B | 109.550 B | 108.129 B | |
| Total current liabilities | 54.170 B | 44.370 B | 46.282 B | 48.725 B | 48.725 B | 53.933 B | 53.933 B | 51.759 B | |
| Accounts Payable | 10.443 B | 8.355 B | 9.632 B | 8.174 B | 8.174 B | 8.848 B | 8.848 B | 8.954 B | |
| Other liabilities | 23.579 B | 21.789 B | 23.428 B | 15.067 B | 24.967 B | 14.086 B | 21.346 B | 14.923 B | |
| Current long term debt | 11.701 B | 3.870 B | 3.451 B | 0.000 | 8.550 B | 0.000 | 9.855 B | 0.000 | |
| Long term debt | 33.901 B | 26.051 B | 25.881 B | 25.082 B | 25.082 B | 31.636 B | 31.636 B | 31.289 B | |
| Other liabilities | 23.579 B | 21.789 B | 23.428 B | 15.067 B | 24.967 B | 14.086 B | 21.346 B | 14.923 B | |
| Minority interest | 1.260 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 75.149 B | 71.228 B | 68.774 B | 70.020 B | 70.020 B | 71.538 B | 71.538 B | 70.158 B | |
| Common stock | 2.598 B | 2.523 B | 2.407 B | 3.120 B | 2.408 B | 3.120 B | 2.407 B | 3.120 B | |
| Retained earnings | 129.381 B | 152.536 B | 153.843 B | 153.378 B | 153.378 B | 155.360 B | 155.360 B | 155.179 B |